Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
225.50    -3.50 (-1.53%)
Bid:
225.00
Ask:
225.50
Spread: 0.50 (0.222%)
Market Cap: £623.32m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Acquisition

6 Jan 2009 07:00

RNS Number : 1429L
Morgan Crucible Co PLC
06 January 2009
 



THE MORGAN CRUCIBLE COMPANY PLC ("MORGAN CRUCIBLE") INCREASES ITS STAKE IN NP AEROSPACE TO BECOME MAJORITY SHAREHOLDER

Morgan Crucible is pleased to announce it will be increasing its equity stake in NP Aerospace from 49% to 60% by acquiring 11% of the ordinary share capital of the company from the management and Employee Benefit Trust for a consideration of £12.2 million. As a result NP Aerospace will be fully consolidated in to the Morgan Crucible accounts with immediate effect.

NP Aerospace is a composite technical moulding and vehicle integration business that develops, manufactures and markets ballistic protective and other composite products in the defence and civil sectors. It is based in CoventryUK with approximately 300 employees and has a strong position in the UK with the Ministry of Defence. NP Aerospace has a high degree of experience and expertise in armour systems for military vehicle protection and has been responsible for integrating a significant number of vehicle systems, including Mastiff, used by the British Army. In addition, NP Aerospace enjoys unique areas of application know-how in products such as personal body armourmilitary helmets, explosive ordnance suits and protective kits for a wide range of vehicles.

The transaction for this 11% tranche of equity has been accelerated from the timetable in the original investment agreement of 1st August 2007 with the consideration payable ultimately dependent on the EBITDA achieved in 2009. Management and the Employee Benefit Trust retain a 40% equity stake and a phased process is in place for Morgan Crucible to acquire this remaining equity in four equal annual instalments starting in early 2010. The consideration payable for the future equity purchases will continue to be based on 7.25 times the EBITDA of the company for the relevant calendar year. 

Mark Robertshaw, Chief Executive Officer of Morgan Crucible said "I am delighted that we have accelerated the programme of purchasing the outstanding equity of NP Aerospace. Since our initial investment in August 2007 the relationship between Morgan Crucible and NP Aerospace has strengthened and both parties have capitalised on the many benefits that we bring to each other. NP Aerospace has enjoyed a year of significant growth in 2008 and is extremely well positioned to continue this track record in 2009, helped by Morgan Crucible's resources and global reach. Being able to consolidate the results of NP Aerospace in Morgan Crucible's accounts also means that the underlying performance and value of the NP Aerospace will now be fully visible in our financial reporting."

Roger Medwell, Chief Executive Officer of NP Aerospace said "Like Morgan Crucible, differentiation of our products by innovative use of our advanced materials continues to be our mission. Since the original investment in 2007, NP Aerospace and Morgan Crucible have worked effectively together, combining our complementary materials, ballistic protective and design expertise to develop a comprehensive range of solutions to defend against ever-changing threats. The NP Aerospace team look forward to working even more closely with Morgan Crucible to meet the demanding requirements of our customers and to capitalise on Morgan Crucible's infrastructure to realise the full potential of the business."

Notes for Class 2 purposes:

The total consideration paid by Morgan Crucible for this additional 11% of NP Aerospace is £12.2 million paid in cash. 10.1% has been acquired as of 5th January 2009 and it has been agreed that a further 0.9% will be acquired from the Employee Benefit Trust within the next two weeks.

In 2007 NP Aerospace revenues were £51.8 million and EBITDA £9.5 million, a margin of 18.4%. As at 31st December 2007 NP Aerospace had gross assets of £36.8 million.

(All the above numbers are quoted from the statutory accounts based on UK GAAP.)

The order book for the business currently stands at approximately £160 million.

For further enquiries:

Mark Robertshaw / Kevin Dangerfield  Morgan Crucible 01753 837300

Mike Smith / Robin Walker Finsbury 020 7251 3801

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAXFSESENEFE
Date   Source Headline
7th Apr 20143:49 pmRNSDirector/PDMR Shareholding
2nd Apr 20145:03 pmRNSAnnual Financial Report
1st Apr 201410:40 amRNSDirector/PDMR Shareholding
31st Mar 20144:21 pmRNSDirector/PDMR Shareholding
28th Mar 201410:14 amRNSDirector/PDMR Shareholding
25th Mar 201411:59 amRNSDirector/PDMR Shareholding
25th Mar 20149:46 amRNSDirector/PDMR Shareholding
24th Mar 20145:05 pmRNSDirector/PDMR Shareholding
3rd Mar 20144:15 pmRNSDirector/PDMR Shareholding
3rd Mar 201412:27 pmRNSDirector/PDMR Shareholding
28th Feb 201412:57 pmRNSDirector/PDMR Shareholding
21st Feb 20142:18 pmRNSDirector/PDMR Shareholding
18th Feb 20149:21 amRNSHolding(s) in Company
13th Feb 20147:00 amRNSFull Year Results
7th Feb 201410:31 amRNSDirectorate Change
16th Dec 201310:42 amRNSBlocklisting Interim Review
10th Dec 20134:54 pmRNSDirector/PDMR Shareholding
9th Dec 201310:40 amRNSDirector/PDMR Shareholding
29th Nov 201311:00 amRNSTotal Voting Rights
21st Nov 20139:00 amRNSCapital Markets Day
20th Nov 20132:29 pmRNSIssue of Equity
14th Nov 20138:54 amRNSHolding(s) in Company
11th Nov 20137:00 amRNSInterim Management Statement
30th Oct 201310:00 amRNSScrip Dividend Price
28th Oct 20134:11 pmRNSHolding(s) in Company
25th Sep 20133:39 pmRNSHolding(s) in Company
12th Sep 20135:14 pmRNSHolding(s) in Company
12th Sep 20134:52 pmRNSHolding(s) in Company
12th Sep 20134:13 pmRNSHolding(s) in Company
22nd Aug 20132:33 pmRNSDirector/PDMR Shareholding
20th Aug 20132:51 pmRNSDirector/PDMR Shareholding
13th Aug 20135:35 pmRNSHolding(s) in Company
8th Aug 20134:14 pmRNSDirector/PDMR Shareholding
8th Aug 20139:35 amRNSHalf Yearly Report
5th Aug 20131:01 pmRNSDirector/PDMR Shareholding
30th Jul 201310:45 amRNSDirector/PDMR Shareholding
24th Jul 20137:00 amRNSHalf Year Results
27th Jun 201310:12 amRNSHolding(s) in Company
24th Jun 201310:36 amRNSBlocklisting Interim Review
7th Jun 20131:40 pmRNSDirector/PDMR Shareholding
5th Jun 20134:43 pmRNSDirector/PDMR Shareholding
4th Jun 201310:52 amRNSHolding(s) in Company
31st May 201310:40 amRNSTotal Voting Rights
31st May 201310:24 amRNSDirector/PDMR Shareholding
28th May 20135:19 pmRNSDirector/PDMR Shareholding
24th May 201312:18 pmRNSIssue of Equity
24th May 201310:12 amRNSNon Regulatory Announcement
22nd May 20134:25 pmRNSDirector/PDMR Shareholding
20th May 201311:39 amRNSDirector/PDMR Shareholding
17th May 201312:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.